Dual Empagliflozin and Sacubitril/Valsartan Therapy Improves Ex Vivo Cardiac Function in a Rat Model of Heart Failure

<b>Background/Objectives:</b> This study aimed to clarify the cardioprotective effects of combined empagliflozin and sacubitril/valsartan therapy in an experimental rat model of heart failure (HF). The main research question was whether dual treatment provides greater functional and molecular benefi...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Maja Murić, Ivan Srejović, Marko Ravić, Jovana Joksimović Jović, Jasmina Sretenović, Marina Nikolić, Nevena Lazarević, Marijana Andjić, Aleksandar Kočović, Sergey Bolevich, Vladimir Jakovljević, Jovana Novaković
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2026-05-01
Serie:	Biomedicines
Soggetti:	heart failure empagliflozin sacubitril/valsartan ex vivo cardiac function gene expression
Accesso online:	https://www.mdpi.com/2227-9059/14/5/1115
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!